Supreme Pharma (CSE: SL) (OTC: SPRWF) announced after the close that it will be issuing convertible notes and warrants in a “bought deal” underwritten by Canaccord Genuity. The $40mm...
Last week, Canadian licensed cannabis producer Supreme Pharma (CSE: SL) (OTC: SPRWF), which operates the 7 Acres hybrid greenhouse cultivation facility in Ontario, announced the closing of the final...
Supreme Pharma (CSE: SL) (OTC: SPRWF), which owns 7 Acres, a 342,000 sq. ft. hybrid greenhouse medical cannabis production facility in Ontario licensed by Health Canada under ACMPR, detailed...
Supreme Pharma (CSE: SL) (OTC: SPRWF), which began cultivating cannabis earlier this year at its 7 Acres facility in Ontario after it received its license from Health Canada on...
Supreme Closes $3.6 Million Private Placement TORONTO, ONTARIO –06/20/16 — Supreme Pharmaceuticals Inc. (the “Company”) (OTC PINK:SPRWF) (CSE:SL) is pleased to announce that it has closed the first tranche...
Supreme Expands B2B Business Through Genetics Agreement TORONTO, ONTARIO, Jun 06, 2016 (Marketwired via COMTEX) — TORONTO, ONTARIO–(Marketwired – Jun 6, 2016) – Supreme Pharmaceuticals Inc. (the “Company” or...
Supreme Secures Multiple Long Term Supply Agreements TORONTO, ONTARIO, May 20, 2016 (Marketwired via COMTEX) — TORONTO, ONTARIO–(Marketwired – May 20, 2016) – Supreme Pharmaceuticals Inc. (the “Company” or...
Supreme Pharma (CSE:SL) (OTCMKTS:SPRWF) received its license from Health Canada to begin cultivating cannabis on March 11th. Based in Kincardine, Ontario, the company owns a large hybrid greenhouse facility,...
Supreme Obtains MMPR License to Cultivate Medical Marijuana TORONTO, ONTARIO–(Marketwired – March 11, 2016) – Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (OTC PINK:SPRWF)(CSE:SL) is pleased to announce its...
After the market close, Supreme Pharma announced that it will receive its pre-license inspection on December. The company, along with several others, has been waiting all year for an...
In a PowerPoint presentation at Kincardine council on Sept. 9, Advanced Medical Marihuana Canada (AMMCan) president and director John Fowler said the regulatory process that began in early 2014...
